19 results on '"Mi, Yingchang"'
Search Results
2. Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) as Induction Treatment in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Phase 2, Multicenter Trial, Single-Arm Trial
3. Pseudomonas aeruginosa bloodstream infection in patients with hematological diseases: Clinical outcomes and prediction model of multidrug-resistant infections
4. The Diagnosis of Chronic Myeloid Leukemia with Deep Adversarial Learning
5. A Higher Dose of Dasatinib May Increase the Possibility of Crossing the Blood–brain Barrier in the Treatment of Patients With Philadelphia Chromosome–positive Acute Lymphoblastic Leukemia
6. Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1–RUNX1T1
7. Auer rods in mixed phenotype acute leukemia, T/myeloid: A report of three cases
8. Clinical characteristics of acute promyelocytic leukemia with the STAT5B-RARA fusion gene
9. MCL-1 Up-Regulation through MAPK Activation Confers Acquired Resistance to BCL-2 Inhibitor ABT-199 in Pre-Clinical AML Models
10. Upregulation of MCL-1 through MAPK Activation Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML
11. EUTOS score predicts survival and cytogenetic response in patients with chronic phase chronic myeloid leukemia treated with first-line imatinib
12. Exogenous expression of WT1 gene influences U937 cell biological behaviors and activates MAPK and JAK-STAT signaling pathways
13. N-Cadherin and Tie2 positive CD34+CD38−CD123+ leukemic stem cell populations can develop acute myeloid leukemia more effectively in NOD/SCID mice
14. Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation
15. Meta-analysis for the potential application of FLT3-TKD mutations as prognostic indicator in non-promyelocytic AML
16. Some novel features of IDH1-mutated acute myeloid leukemia revealed in Chinese patients
17. RAD51 and XRCC3 polymorphisms: Impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ–MYH11(+) acute myeloid leukemia
18. Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38−/CD123+ leukemic stem cells by chemotherapy-resistance
19. Apoptosis in Leukemia Cells Is Accompanied by Alterations in the Levels and Localization of Nucleolin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.